MERU / M16-298 - Hosted By Mondien
A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer
| Study Type | Interventional (Clinical Trial) |
| Sponsor Name | Abbvie |
| Disease type | Small Cell Lung Cancer |
| Disease Stage | IV |
| Clinical Status | Maintenance Therapy |
| Phase | III |
| Intervention / Treatment | Rovalpituzumab Teserine |
| Research Site | IUCPQ |
| Investigator | Dre Lise Tremblay |
| Coordinator | Brigitte Fortn |
| Telephone number | |
| Fax number | |
| Study start date | 26-Jan-17 |
| Study end date | – |
| Trial Status | Recruiting |
